XK and influenza: Some studies have attempted to improve the replication efficiency of vaccine viruses by using reassortant viruses or viruses encoding chimeric or mutated HA and/or NA proteins22, 23, 24, 25, 26, 27; to date, none of these studies has resulted in commercially available, improved influenza vaccine production.